CHI-X 2 HAS NO ADVERSE AFFECTS ON CANADIAN MARKET – CMCRC STUDY

New research released by the Capital Markets Cooperative Research Centre (CMCRC) examines Canadian market quality in the wake of the introduction of Chi-X 2.
Source: Finextra